Welcome to
Gilead Medical Information

This site is an online medical resource that provides access to scientific information about Gilead products and related information. The information provided is not intended to be and should not be understood to provide medical advice.

Choose an option that describes you:

By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.

ESMO Asia 2024

ESMO Asia 2024
December 06-08, 2024
Singapore, Republic of Singapore

European Society for Medical Oncology Asia Congress 2024 .

Explore more information for Gilead Oncology therapies

Material Type

Oral Presentation

Filter by Keyword(s)

Results (1)

TROPiCS-04: A Randomized Phase 3 Study of Sacituzumab Govitecan vs Chemotherapy in Pretreated Advanced Urothelial Carcinoma

Author(s): Grivas, P

trodelvy
Oncology
Trodelvy
Sacituzumab
SG
mUC
Urothelial

View Oral Presentation

Welcome to Gilead Medical Information

Choose an option that describes you:

ESMO Asia 2024

Filter results with keywords such as:

TROPiCS-04: A Randomized Phase 3 Study of Sacituzumab Govitecan vs Chemotherapy in Pretreated Advanced Urothelial Carcinoma

Chat

Medical Inquiry

Meeting Request

You are leaving this website

Welcome to
Gilead Medical Information